Comprehensive Analysis of Microsatellite Instability in Canine Cancers: Implications for Comparative Oncology and Personalized Veterinary Medicine
Abstract
:Simple Summary
Abstract
1. Introduction
2. Materials and Methods
2.1. Sample Acquisition and Selection Criteria
2.2. Data Preprocessing
2.3. Panel of Normals
2.4. Variant Calling
2.5. Tumor Mutational Burden Analysis
2.6. Microsatellite Instability Analysis
2.7. Statistical Analysis
3. Results
3.1. Microsatellite Instability
3.2. Correlation between Tumor Mutational Burden and MSI Status
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Tautz, D. Notes on the Definition and Nomenclature of Tandemly Repetitive DNA Sequences. EXS 1993, 67, 21–28. [Google Scholar] [CrossRef]
- Murphy, K.M.; Zhang, S.; Geiger, T.; Hafez, M.J.; Bacher, J.; Berg, K.D.; Eshleman, J.R. Comparison of the Microsatellite Instability Analysis System and the Bethesda Panel for the Determination of Microsatellite Instability in Colorectal Cancers. J. Mol. Diagn. 2006, 8, 305–311. [Google Scholar] [CrossRef]
- Imai, K.; Yamamoto, H. Carcinogenesis and Microsatellite Instability: The Interrelationship between Genetics and Epigenetics. Carcinogenesis 2008, 29, 673–680. [Google Scholar] [CrossRef] [PubMed]
- Boland, C.R.; Thibodeau, S.N.; Hamilton, S.R.; Sidransky, D.; Eshleman, J.R.; Burt, R.W.; Meltzer, S.J.; Rodriguez-Bigas, M.A.; Fodde, R.; Ranzani, G.N.; et al. A National Cancer Institute Workshop on Microsatellite Instability for Cancer Detection and Familial Predisposition: Development of International Criteria for the Determination of Microsatellite Instability in Colorectal Cancer. Cancer Res. 1998, 58, 5248–5257. [Google Scholar] [PubMed]
- Salipante, S.J.; Scroggins, S.M.; Hampel, H.L.; Turner, E.H.; Pritchard, C.C. Microsatellite Instability Detection by next Generation Sequencing. Clin. Chem. 2014, 60, 1192–1199. [Google Scholar] [CrossRef]
- Niu, B.; Ye, K.; Zhang, Q.; Lu, C.; Xie, M.; McLellan, M.D.; Wendl, M.C.; Ding, L. MSIsensor: Microsatellite Instability Detection Using Paired Tumor-Normal Sequence Data. Bioinformatics 2014, 30, 1015–1016. [Google Scholar] [CrossRef] [PubMed]
- Kautto, E.A.; Bonneville, R.; Miya, J.; Yu, L.; Krook, M.A.; Reeser, J.W.; Roychowdhury, S. Performance Evaluation for Rapid Detection of Pan-Cancer Microsatellite Instability with MANTIS. Oncotarget 2017, 8, 7452–7463. [Google Scholar] [CrossRef]
- Bonneville, R.; Krook, M.A.; Kautto, E.A.; Miya, J.; Wing, M.R.; Chen, H.-Z.; Reeser, J.W.; Yu, L.; Roychowdhury, S. Landscape of Microsatellite Instability Across 39 Cancer Types. JCO Precis. Oncol. 2017, 1, 1–15. [Google Scholar] [CrossRef]
- Hause, R.J.; Pritchard, C.C.; Shendure, J.; Salipante, S.J. Classification and Characterization of Microsatellite Instability across 18 Cancer Types. Nat. Med. 2016, 22, 1342–1350. [Google Scholar] [CrossRef]
- Le, D.T.; Uram, J.N.; Wang, H.; Bartlett, B.R.; Kemberling, H.; Eyring, A.D.; Skora, A.D.; Luber, B.S.; Azad, N.S.; Laheru, D.; et al. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N. Engl. J. Med. 2015, 372, 2509–2520. [Google Scholar] [CrossRef]
- McNiel, E.A.; Griffin, K.L.; Mellett, A.M.; Madrill, N.J.; Mickelson, J.R. Microsatellite Instability in Canine Mammary Gland Tumors. Vet. Intern. Medicne 2007, 21, 1034–1040. [Google Scholar] [CrossRef]
- Sotirakopoulos, A.J.; Armstrong, P.J.; Heath, L.; Madrill, N.J.; McNiel, E.A. Evaluation of Microsatellite Instability in Urine for the Diagnosis of Transitional Cell Carcinoma of the Lower Urinary Tract in Dogs: Microsatellite Instability in TCC. J. Vet. Intern. Med. 2010, 24, 1445–1451. [Google Scholar] [CrossRef]
- Inanaga, S.; Igase, M.; Sakai, Y.; Tanabe, M.; Shimonohara, N.; Itamoto, K.; Nakaichi, M.; Mizuno, T. Mismatch Repair Deficiency in Canine Neoplasms. Vet. Pathol. 2021, 58, 1058–1063. [Google Scholar] [CrossRef]
- Jia, P.; Yang, X.; Guo, L.; Liu, B.; Lin, J.; Liang, H.; Sun, J.; Zhang, C.; Ye, K. MSIsensor-Pro: Fast, Accurate, and Matched-Normal-Sample-Free Detection of Microsatellite Instability. Genom. Proteom. Bioinform. 2020, 18, 65–71. [Google Scholar] [CrossRef] [PubMed]
- Bai, B.; Zhao, W.-M.; Tang, B.-X.; Wang, Y.-Q.; Wang, L.; Zhang, Z.; Yang, H.-C.; Liu, Y.-H.; Zhu, J.-W.; Irwin, D.M.; et al. DoGSD: The Dog and Wolf Genome SNP Database. Nucleic Acids Res. 2015, 43, D777–D783. [Google Scholar] [CrossRef] [PubMed]
- Cezard, T.; Cunningham, F.; Hunt, S.E.; Koylass, B.; Kumar, N.; Saunders, G.; Shen, A.; Silva, A.F.; Tsukanov, K.; Venkataraman, S.; et al. The European Variation Archive: A FAIR Resource of Genomic Variation for All Species. Nucleic Acids Res. 2022, 50, D1216–D1220. [Google Scholar] [CrossRef]
- Li, H.; Durbin, R. Fast and Accurate Long-Read Alignment with Burrows-Wheeler Transform. Bioinformatics 2010, 26, 589–595. [Google Scholar] [CrossRef] [PubMed]
- McKenna, A.; Hanna, M.; Banks, E.; Sivachenko, A.; Cibulskis, K.; Kernytsky, A.; Garimella, K.; Altshuler, D.; Gabriel, S.; Daly, M.; et al. The Genome Analysis Toolkit: A MapReduce Framework for Analyzing next-Generation DNA Sequencing Data. Genome Res. 2010, 20, 1297–1303. [Google Scholar] [CrossRef]
- Cibulskis, K.; Lawrence, M.S.; Carter, S.L.; Sivachenko, A.; Jaffe, D.; Sougnez, C.; Gabriel, S.; Meyerson, M.; Lander, E.S.; Getz, G. Sensitive Detection of Somatic Point Mutations in Impure and Heterogeneous Cancer Samples. Nat. Biotechnol. 2013, 31, 213–219. [Google Scholar] [CrossRef]
- Kim, S.; Scheffler, K.; Halpern, A.L.; Bekritsky, M.A.; Noh, E.; Källberg, M.; Chen, X.; Kim, Y.; Beyter, D.; Krusche, P.; et al. Strelka2: Fast and Accurate Calling of Germline and Somatic Variants. Nat. Methods 2018, 15, 591–594. [Google Scholar] [CrossRef]
- Koboldt, D.C.; Zhang, Q.; Larson, D.E.; Shen, D.; McLellan, M.D.; Lin, L.; Miller, C.A.; Mardis, E.R.; Ding, L.; Wilson, R.K. VarScan 2: Somatic Mutation and Copy Number Alteration Discovery in Cancer by Exome Sequencing. Genome Res. 2012, 22, 568–576. [Google Scholar] [CrossRef] [PubMed]
- Wang, K.; Li, M.; Hakonarson, H. ANNOVAR: Functional Annotation of Genetic Variants from High-Throughput Sequencing Data. Nucleic Acids Res. 2010, 38, e164. [Google Scholar] [CrossRef]
- Llosa, N.J.; Cruise, M.; Tam, A.; Wicks, E.C.; Hechenbleikner, E.M.; Taube, J.M.; Blosser, R.L.; Fan, H.; Wang, H.; Luber, B.S.; et al. The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints. Cancer Discov. 2015, 5, 43–51. [Google Scholar] [CrossRef]
- Maekawa, N.; Konnai, S.; Takagi, S.; Kagawa, Y.; Okagawa, T.; Nishimori, A.; Ikebuchi, R.; Izumi, Y.; Deguchi, T.; Nakajima, C.; et al. A Canine Chimeric Monoclonal Antibody Targeting PD-L1 and Its Clinical Efficacy in Canine Oral Malignant Melanoma or Undifferentiated Sarcoma. Sci. Rep. 2017, 7, 8951. [Google Scholar] [CrossRef] [PubMed]
- Shosu, K.; Sakurai, M.; Inoue, K.; Nakagawa, T.; Sakai, H.; Morimoto, M.; Okuda, M.; Noguchi, S.; Mizuno, T. Programmed Cell Death Ligand 1 Expression in Canine Cancer. In Vivo 2016, 30, 195–204. [Google Scholar] [PubMed]
- Pantelyushin, S.; Ranninger, E.; Guerrera, D.; Hutter, G.; Maake, C.; Markkanen, E.; Bettschart-Wolfensberger, R.; Rohrer Bley, C.; Läubli, H.; Vom Berg, J. Cross-Reactivity and Functionality of Approved Human Immune Checkpoint Blockers in Dogs. Cancers 2021, 13, 785. [Google Scholar] [CrossRef]
- Yoshimoto, S.; Chester, N.; Xiong, A.; Radaelli, E.; Wang, H.; Brillantes, M.; Gulendran, G.; Glassman, P.; Siegel, D.L.; Mason, N.J. Development and Pharmacokinetic Assessment of a Fully Canine Anti-PD-1 Monoclonal Antibody for Comparative Translational Research in Dogs with Spontaneous Tumors. MAbs 2023, 15, 2287250. [Google Scholar] [CrossRef]
- Marcus, L.; Lemery, S.J.; Keegan, P.; Pazdur, R. FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors. Clin. Cancer Res. 2019, 25, 3753–3758. [Google Scholar] [CrossRef]
- Bushell, K.R.; Kim, Y.; Chan, F.C.; Ben-Neriah, S.; Jenks, A.; Alcaide, M.; Fornika, D.; Grande, B.M.; Arthur, S.; Gascoyne, R.D.; et al. Genetic inactivation of TRAF3 in canine and human B-cell lymphoma. Blood 2015, 125, 999–1005. [Google Scholar] [CrossRef]
- Giannuzzi, D.; Marconato, L.; Fanelli, A.; Licenziato, L.; De Maria, R.; Rinaldi, A.; Rotta, L.; Rouquet, N.; Birolo, G.; Fariselli, P.; et al. The genomic landscape of canine diffuse large B-cell lymphoma identifies distinct subtypes with clinical and therapeutic implications. Lab Anim. 2022, 51, 191–202. [Google Scholar] [CrossRef]
- Elvers, I.; Turner-Maier, J.; Swofford, R.; Koltookian, M.; Johnson, J.; Stewart, C.; Zhang, C.Z.; Schumacher, S.E.; Beroukhim, R.; Rosenberg, M.; et al. Exome sequencing of lymphomas from three dog breeds reveals somatic mutation patterns reflecting genetic background. Genome Res. 2015, 25, 1634–1645. [Google Scholar] [CrossRef]
- Lee, K.H.; Hwang, H.J.; Noh, H.J.; Shin, T.J.; Cho, J.Y. Somatic Mutation of PIK3CA (H1047R) Is a Common Driver Mutation Hotspot in Canine Mammary Tumors as Well as Human Breast Cancers. Cancers 2019, 11, 2006. [Google Scholar] [CrossRef]
- Kim, K.K.; Seung, B.J.; Kim, D.; Park, H.M.; Lee, S.; Song, D.W.; Lee, G.; Cheong, J.H.; Nam, H.; Sur, J.H.; et al. Whole-exome and whole-transcriptome sequencing of canine mammary gland tumors. Sci. Data 2019, 6, 147. [Google Scholar] [CrossRef]
- Amin, S.B.; Anderson, K.J.; Boudreau, C.E.; Martinez-Ledesma, E.; Kocakavuk, E.; Johnson, K.C.; Barthel, F.P.; Varn, F.S.; Kassab, C.; Ling, X.; et al. Comparative Molecular Life History of Spontaneous Canine and Human Gliomas. Cancer Cell 2020, 37, 243–257.e7. [Google Scholar] [CrossRef]
- Wang, G.; Wu, M.; Maloneyhuss, M.A.; Wojcik, J.; Durham, A.C.; Mason, N.J.; Roth, D.B. Actionable mutations in canine hemangiosarcoma. PLoS ONE 2017, 12, e0188667. [Google Scholar] [CrossRef]
- Megquier, K.; Turner-Maier, J.; Swofford, R.; Kim, J.H.; Sarver, A.L.; Wang, C.; Sakthikumar, S.; Johnson, J.; Koltookian, M.; Lewellen, M.; et al. Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human Angiosarcoma. Mol. Cancer Res. 2019, 17, 2410–2421. [Google Scholar] [CrossRef]
- Wong, S.; Ehrhart, E.J.; Stewart, S.; Zismann, V.; Cawley, J.; Halperin, R.; Briones, N.; Richter, K.; Sivaprakasam, K.; Perdigones, N.; et al. Genomic landscapes of canine splenic angiosarcoma (hemangiosarcoma) contain extensive heterogeneity within and between patients. PLoS ONE 2022, 17, e0264986. [Google Scholar] [CrossRef]
- Vozdova, M.; Kubickova, S.; Pal, K.; Fröhlich, J.; Fictum, P.; Rubes, J. Recurrent gene mutations detected in canine mast cell tumours by next generation sequencing. Vet. Comp. Oncol. 2020, 18, 509–518. [Google Scholar] [CrossRef]
- Wong, K.; van der Weyden, L.; Schott, C.R.; Foote, A.; Constantino-Casas, F.; Smith, S.; Dobson, J.M.; Murchison, E.P.; Wu, H.; Yeh, I.; et al. Cross-species genomic landscape comparison of human mucosal melanoma with canine oral and equine melanoma. Nat. Commun. 2019, 10, 353. [Google Scholar] [CrossRef]
- Giannuzzi, D.; Marconato, L.; Elgendy, R.; Ferraresso, S.; Scarselli, E.; Fariselli, P.; Nicosia, A.; Pegolo, S.; Leoni, G.; Laganga, P.; et al. Longitudinal transcriptomic and genetic landscape of radiotherapy response in canine melanoma. Vet. Comp. Oncol. 2019, 17, 308–316. [Google Scholar] [CrossRef]
- Prouteau, A.; Mottier, S.; Primot, A.; Cadieu, E.; Bachelot, L.; Botherel, N.; Cabillic, F.; Houel, A.; Cornevin, L.; Kergal, C.; et al. Canine Oral Melanoma Genomic and Transcriptomic Study Defines Two Molecular Subgroups with Different Therapeutical Targets. Cancers 2022, 14, 276. [Google Scholar] [CrossRef]
- Gardner, H.L.; Sivaprakasam, K.; Briones, N.; Zismann, V.; Perdigones, N.; Drenner, K.; Facista, S.; Richholt, R.; Liang, W.; Aldrich, J.; et al. Canine osteosarcoma genome sequencing identifies recurrent mutations in DMD and the histone methyltransferase gene SETD2. Commun. Biol. 2019, 2, 266. [Google Scholar] [CrossRef]
- Sakthikumar, S.; Elvers, I.; Kim, J.; Arendt, M.L.; Thomas, R.; Turner-Maier, J.; Swofford, R.; Johnson, J.; Schumacher, S.E.; Alföldi, J.; et al. SETD2 Is Recurrently Mutated in Whole-Exome Sequenced Canine Osteosarcoma. Cancer Res. 2018, 78, 3421–3431. [Google Scholar] [CrossRef]
- Chu, S.; Skidmore, Z.L.; Kunisaki, J.; Walker, J.R.; Griffith, M.; Griffith, O.L.; Bryan, J.N. Unraveling the chaotic genomic landscape of primary and metastatic canine appendicular osteosarcoma with current sequencing technologies and bioinformatic approaches. PLoS ONE 2021, 16, e0246443. [Google Scholar] [CrossRef]
- Das, S.; Idate, R.; Regan, D.P.; Fowles, J.S.; Lana, S.E.; Thamm, D.H.; Gustafson, D.L.; Duval, D.L. Immune pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma. Commun. Biol. 2021, 4, 1178. [Google Scholar] [CrossRef]
- Lorch, G.; Sivaprakasam, K.; Zismann, V.; Perdigones, N.; Contente-Cuomo, T.; Nazareno, A.; Facista, S.; Wong, S.; Drenner, K.; Liang, W.S.; et al. Identification of Recurrent Activating HER2 Mutations in Primary Canine Pulmonary Adenocarcinoma. Clin. Cancer Res. 2019, 25, 5866–5877. [Google Scholar] [CrossRef]
- Cronise, K.E.; Das, S.; Hernandez, B.G.; Regan, D.P.; Dailey, D.D.; McGeachan, R.I.; Lana, S.E.; Page, R.L.; Gustafson, D.L.; Duval, D.L. Characterizing the molecular and immune landscape of canine bladder cancer. Vet. Comp. Oncol. 2022, 20, 69–81. [Google Scholar] [CrossRef]
- Ramsey, S.A.; Xu, T.; Goodall, C.; Rhodes, A.C.; Kashyap, A.; He, J.; Bracha, S. Cross-species analysis of the canine and human bladder cancer transcriptome and exome. Genes Chromosomes Cancer 2017, 56, 328–343. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Mazzone, E.; Aresu, L. Comprehensive Analysis of Microsatellite Instability in Canine Cancers: Implications for Comparative Oncology and Personalized Veterinary Medicine. Animals 2024, 14, 2484. https://doi.org/10.3390/ani14172484
Mazzone E, Aresu L. Comprehensive Analysis of Microsatellite Instability in Canine Cancers: Implications for Comparative Oncology and Personalized Veterinary Medicine. Animals. 2024; 14(17):2484. https://doi.org/10.3390/ani14172484
Chicago/Turabian StyleMazzone, Eugenio, and Luca Aresu. 2024. "Comprehensive Analysis of Microsatellite Instability in Canine Cancers: Implications for Comparative Oncology and Personalized Veterinary Medicine" Animals 14, no. 17: 2484. https://doi.org/10.3390/ani14172484